Industry News

Robertet Invests in Aethera Biotech

The supplier is expanding its portfolio of cosmetic active ingredients with biotechnology.

Biotechnology is big for 2026 and Robertet is expanding its partnership with Aethera Biotech through a strategic investment.

According to the company, this joint venture creates “synergies between two family-owned groups sharing common values and a long-term vision.”

Founded in 2016, Aethera Biotech specializes in the research, development and production of active ingredients from cell multiplication process.

Aethera Biotech is a subsidiary of the Italian family-owned group Cereal Docks. According to the company, it is a “pioneer in phyto-complex biotechnologies through its proprietary, multi-patented CROP (Controlled Release of Optimized Plants) platform.”

Inspired by natural plant mechanisms, this technology enables the secure production of natural extracts in controlled conditions, independent of climatic, agricultural or geopolitical constraints.

By significantly reducing environmental impact, CROP offers a sustainable and high-performance alternative to traditional production methods, illustrating the concept of “Augmented Naturality.”

Based in Camisano Vicentino, Aethera Biotech employs a team of 25 professionals covering all biotech functions from R&D to industrialization. Its portfolio has eight patents covering both products and the proprietary CROP technology.

Looking for more sustainability news? Check out our recent story here.

Through this reinforced partnership, Robertet initiates a new, targeted biotech strategy focused on the development of advanced cosmetic active ingredients.

According to the company, the collaboration will enable Robertet to:

Strengthen its biotechnology expertise by integrating a proven scientific team and an efficient industrial platform, establishing Aethera Biotech as a center of excellence for future biotech developments across the group.

Enter the market for topical cosmetic active ingredients, with a unique and innovative portfolio supporting the growth strategy of the Health & Beauty division.

Secure sustainable and resilient access to innovative natural ingredients regardless of climatic, agricultural or geopolitical uncertainties.

Support long-term growth by commercializing Aethera Biotech’s portfolio through Robertet’s global distribution network, particularly within the Fragrance division.

Robertet’s progressive investment in the joint venture will be completed in two phases over a three-year period under certain conditions.

Executive Insight

Jérôme Bruhat, chief executive officer of Robertet, stated: “We are pleased to strengthen our partnership with Aethera Biotech, marking a significant step forward for Robertet into the field of biotechnology, a domain with strong long-term potential. This joint venture reflects our conviction that biotech will play an increasingly important role in the development of high-value sustainable solutions. It supports our ambition to reinforce our leadership in naturals while opening new pathways for innovation and growth for our customers.”

Olivier Maubert, group innovation director and head of the Health & Beauty division at Robertet, commented: “After nearly two years of close collaboration, this next step further advances our vision of Augmented Naturality and reflects the strong alignment between two family-owned groups sharing the same values. Aethera Biotech’s CROP technology offers a unique and complementary approach to developing natural extracts and active cosmetic ingredients, enabling us to address growing market demand while accelerating innovation in skin science, a key pillar of our Health & Beauty roadmap.”

In other news, Robertet recently rolled out an e-commerce platform in the US and Canada, as reported in Happi.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters